Page last updated: 2024-08-17

mannitol and abacavir

mannitol has been researched along with abacavir in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Elmquist, WF; Giri, N; Shaik, N	1

Reviews

1 review(s) available for mannitol and abacavir

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for mannitol and abacavir

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Investigation of the micellar effect of pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies. Journal of pharmaceutical sciences, 2009, Volume: 98, Issue:11 Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Cell Line; Cell-Free System; Cells; Dialysis; Dideoxynucleosides; Diphenylhexatriene; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fluorescent Dyes; HIV-1; Inhibitory Concentration 50; Mannitol; Micelles; Nelfinavir; Permeability; Poloxamer; Protease Inhibitors; Saquinavir; Surface-Active Agents; Temperature; Tetrahydroisoquinolines; Time Factors	2009

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011

Investigation of the micellar effect of pluronic P85 on P-glycoprotein inhibition: cell accumulation and equilibrium dialysis studies.

Journal of pharmaceutical sciences, 2009, Volume: 98, Issue:11

Topics: Acridines; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Cell Line; Cell-Free System; Cells; Dialysis; Dideoxynucleosides; Diphenylhexatriene; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Fluorescent Dyes; HIV-1; Inhibitory Concentration 50; Mannitol; Micelles; Nelfinavir; Permeability; Poloxamer; Protease Inhibitors; Saquinavir; Surface-Active Agents; Temperature; Tetrahydroisoquinolines; Time Factors

2009